Ternak Semut
Penjelasan Tehknis
cari bibit semut yang sebesar bola kaki dan juga lama ga di unduh, kalau pernah diunduh takutnya Ratu semutnya ikut keunduh/ mati ataupun jatuh ditanah. untuk mengambil sarangnya, sediakan sabit/ arit, sak beras/ padi yang ukuran 50 kg dan juga tali rafia.
ok lanjut ya...
setelah tahu keberadaan sarang semut tunggulah sampai petang dulu, kalau siang biasanya semut pada keluar. usahakan pengambilan setelah mahgrib karena kalau hari sudah petang para semut akan masuk semua disarangnya. buka sak beras yang sudah disiapkan, masukkan berlahan jangan sampai membuat kaget atau semut akan bubar kemana mana. setelah yakin sarang semut masuk dalam sak tali sak semennya dengan rafia biar semut ga pergi, kalaupun bubar semut sudah di dalam sak. setelah di tali sak padinya potong dahan/ ranting tempat sarang semut, bawa pulang dengan hati - hati, jangang di goyang/ di kentrok kentrok.
sampai di rumah.....
buka tali rafia secara berlahan, tumpahkan sarang semut kedalam box yang sudah dipersiapkan. siapkan abu yang lembut lalu olesi/ lumuri kedua tangan dengan abu, bongkar sarang semutnya, obrak abrik semuanya biar semua semut pada kabur/ mubal di dalam box. buang semua daun yang tadi dipakai buat sarang semut, biasanya dalam 2 hari semut akan masuk kedalam bambu/ pring dan siap bertelur.
Sick American dogs get first shot at cancer drugs
Dogs with cancer in the US are now entitled to receive experimental drugs – before the drugs are available for humans. Twelve trials are under way on groups of 15 to 60 dogs, and in several of them cancers have disappeared.
"We've had dramatic remissions in dogs with really aggressive cancers," says Chand Khanna, head of the Comparative Oncology Trials Consortium newly formed in Bethesda, Maryland, by the US National Cancer Institute. "We've also had responses allowing dogs to have their original cancers surgically removed," he says.
Forget mice and rats
The rationale is that unlike mice and rats, which are kept in a highly regimented experimental setting, pet dogs experience cancer in a similar way to humans. As in people, cancers in dogs spread to form secondaries and can become resistant to drugs, and the animals can have relapses.
Not only that, but dogs suffer from cancers as variable as those affecting humans, so treating them gives us a much better idea of what would happen in a cross-section of humans than we could gain from lab studies of mice.
The consortium consists of 19 veterinary schools, and there are plans to extend it to Europe. Owners can opt for conventional drugs or experimental ones, including some that are untested in humans and others that are already undergoing trials, but that need additional animal data – for example on dosing – before they can proceed to the next stage.
As well as looking after their sick dog, owners can help gather data for the researchers. "They're given notebooks so that they can complete assessments of quality of life, appetite, demeanour and perhaps even collect some specimens," says Khanna.
Sensitive area
Because owners carry on caring for the dogs, and because the hope is that pet dogs will get better as a result of the treatment, the approach also challenges claims by antivivisectionists that all experimentation on animals is wrong. "I understand their sensitivities, and we've had informed discussions with individuals, and some do see the value of helping dogs with cancer in this way," says Khanna.
"This raises serious concerns with respect to what the dogs may have to endure," says Nedim Buyukmihci, a vet consultant to the British Union for the Abolition of Vivisection.
Every dog matters
Khanna says, however, that the top priority for every dog is their well-being. "It's important that the trials are designed with the care of the animals as priority, and also that there's an informed consent process each time," he says.
Cancer researchers in Europe are watching closely to see whether to join the consortium. "Studying dogs, with their owners' consent and following ethical guidelines, after they have naturally developed cancer, is an interesting approach to learning more about the disease," says Joanna Owens, communications manager at the Cancer Research UK charity in London. "We look forward to following the progress of this initiative and the findings that come out of their research."
www.newscientist.com
"We've had dramatic remissions in dogs with really aggressive cancers," says Chand Khanna, head of the Comparative Oncology Trials Consortium newly formed in Bethesda, Maryland, by the US National Cancer Institute. "We've also had responses allowing dogs to have their original cancers surgically removed," he says.
Forget mice and rats
The rationale is that unlike mice and rats, which are kept in a highly regimented experimental setting, pet dogs experience cancer in a similar way to humans. As in people, cancers in dogs spread to form secondaries and can become resistant to drugs, and the animals can have relapses.
Not only that, but dogs suffer from cancers as variable as those affecting humans, so treating them gives us a much better idea of what would happen in a cross-section of humans than we could gain from lab studies of mice.
The consortium consists of 19 veterinary schools, and there are plans to extend it to Europe. Owners can opt for conventional drugs or experimental ones, including some that are untested in humans and others that are already undergoing trials, but that need additional animal data – for example on dosing – before they can proceed to the next stage.
As well as looking after their sick dog, owners can help gather data for the researchers. "They're given notebooks so that they can complete assessments of quality of life, appetite, demeanour and perhaps even collect some specimens," says Khanna.
Sensitive area
Because owners carry on caring for the dogs, and because the hope is that pet dogs will get better as a result of the treatment, the approach also challenges claims by antivivisectionists that all experimentation on animals is wrong. "I understand their sensitivities, and we've had informed discussions with individuals, and some do see the value of helping dogs with cancer in this way," says Khanna.
"This raises serious concerns with respect to what the dogs may have to endure," says Nedim Buyukmihci, a vet consultant to the British Union for the Abolition of Vivisection.
Every dog matters
Khanna says, however, that the top priority for every dog is their well-being. "It's important that the trials are designed with the care of the animals as priority, and also that there's an informed consent process each time," he says.
Cancer researchers in Europe are watching closely to see whether to join the consortium. "Studying dogs, with their owners' consent and following ethical guidelines, after they have naturally developed cancer, is an interesting approach to learning more about the disease," says Joanna Owens, communications manager at the Cancer Research UK charity in London. "We look forward to following the progress of this initiative and the findings that come out of their research."
www.newscientist.com
Subscribe to:
Posts (Atom)
